On the other hand, the expression of PD-L1 on tumor cells could also be increased by activating intracellular signaling pathways, such as IFN-γ/JAK2/IFN, ALK/STAT3, PI3K and MEK/ERK/STAT1 (99, 100). The gene discussed is CD274; the disease is neoplasm.